These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22559880)

  • 1. Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions.
    Tosh DK; Deflorian F; Phan K; Gao ZG; Wan TC; Gizewski E; Auchampach JA; Jacobson KA
    J Med Chem; 2012 May; 55(10):4847-60. PubMed ID: 22559880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionalized congeners of A3 adenosine receptor-selective nucleosides containing a bicyclo[3.1.0]hexane ring system.
    Tosh DK; Chinn M; Ivanov AA; Klutz AM; Gao ZG; Jacobson KA
    J Med Chem; 2009 Dec; 52(23):7580-92. PubMed ID: 19499950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.
    Tchilibon S; Joshi BV; Kim SK; Duong HT; Gao ZG; Jacobson KA
    J Med Chem; 2005 Mar; 48(6):1745-58. PubMed ID: 15771421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of truncated C2- or C8-substituted adenosine derivatives as dual acting A₂A and A₃ adenosine receptor ligands.
    Hou X; Majik MS; Kim K; Pyee Y; Lee Y; Alexander V; Chung HJ; Lee HW; Chandra G; Lee JH; Park SG; Choi WJ; Kim HO; Phan K; Gao ZG; Jacobson KA; Choi S; Lee SK; Jeong LS
    J Med Chem; 2012 Jan; 55(1):342-56. PubMed ID: 22142423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Dialkynyl derivatives of (N)-methanocarba nucleosides: 'Clickable' A(3) adenosine receptor-selective agonists.
    Tosh DK; Chinn M; Yoo LS; Kang DW; Luecke H; Gao ZG; Jacobson KA
    Bioorg Med Chem; 2010 Jan; 18(2):508-17. PubMed ID: 20036562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and in Vivo Characterization of A
    Tosh DK; Rao H; Bitant A; Salmaso V; Mannes P; Lieberman DI; Vaughan KL; Mattison JA; Rothwell AC; Auchampach JA; Ciancetta A; Liu N; Cui Z; Gao ZG; Reitman ML; Gavrilova O; Jacobson KA
    J Med Chem; 2019 Feb; 62(3):1502-1522. PubMed ID: 30605331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A₂A adenosine receptor.
    Deflorian F; Kumar TS; Phan K; Gao ZG; Xu F; Wu H; Katritch V; Stevens RC; Jacobson KA
    J Med Chem; 2012 Jan; 55(1):538-52. PubMed ID: 22104008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended N(6) substitution of rigid C2-arylethynyl nucleosides for exploring the role of extracellular loops in ligand recognition at the A3 adenosine receptor.
    Tosh DK; Paoletta S; Chen Z; Moss SM; Gao ZG; Salvemini D; Jacobson KA
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3302-6. PubMed ID: 24969016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective A(3) adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system.
    Melman A; Wang B; Joshi BV; Gao ZG; Castro Sd; Heller CL; Kim SK; Jeong LS; Jacobson KA
    Bioorg Med Chem; 2008 Sep; 16(18):8546-56. PubMed ID: 18752961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Click modification in the N6 region of A3 adenosine receptor-selective carbocyclic nucleosides for dendrimeric tethering that preserves pharmacophore recognition.
    Tosh DK; Phan K; Deflorian F; Wei Q; Yoo LS; Gao ZG; Jacobson KA
    Bioconjug Chem; 2012 Feb; 23(2):232-47. PubMed ID: 22175234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.
    Gao ZG; Kim SK; Biadatti T; Chen W; Lee K; Barak D; Kim SG; Johnson CR; Jacobson KA
    J Med Chem; 2002 Sep; 45(20):4471-84. PubMed ID: 12238926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo phenotypic screening for treating chronic neuropathic pain: modification of C2-arylethynyl group of conformationally constrained A3 adenosine receptor agonists.
    Tosh DK; Finley A; Paoletta S; Moss SM; Gao ZG; Gizewski ET; Auchampach JA; Salvemini D; Jacobson KA
    J Med Chem; 2014 Dec; 57(23):9901-14. PubMed ID: 25422861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
    Volpini R; Dal Ben D; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
    J Med Chem; 2007 Mar; 50(6):1222-30. PubMed ID: 17309246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-triazole-substituted adenosines: a new class of selective A3 adenosine receptor agonists, partial agonists, and antagonists.
    Cosyn L; Palaniappan KK; Kim SK; Duong HT; Gao ZG; Jacobson KA; Van Calenbergh S
    J Med Chem; 2006 Dec; 49(25):7373-83. PubMed ID: 17149867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of (N)-methanocarba adenosine 5'-uronamides as species-independent A3 receptor-selective agonists.
    Melman A; Gao ZG; Kumar D; Wan TC; Gizewski E; Auchampach JA; Jacobson KA
    Bioorg Med Chem Lett; 2008 May; 18(9):2813-9. PubMed ID: 18424135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Truncated Nucleosides as A(3) Adenosine Receptor Ligands: Combined 2-Arylethynyl and Bicyclohexane Substitutions.
    Tosh DK; Paoletta S; Phan K; Gao ZG; Jacobson KA
    ACS Med Chem Lett; 2012 Jul; 3(7):596-601. PubMed ID: 23145215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Truncated (N)-Methanocarba Nucleosides as Partial Agonists at Mouse and Human A
    Tosh DK; Salmaso V; Rao H; Bitant A; Fisher CL; Lieberman DI; Vorbrüggen H; Reitman ML; Gavrilova O; Gao ZG; Auchampach JA; Jacobson KA
    J Med Chem; 2020 Apr; 63(8):4334-4348. PubMed ID: 32271569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists.
    Pal S; Choi WJ; Choe SA; Heller CL; Gao ZG; Chinn M; Jacobson KA; Hou X; Lee SK; Kim HO; Jeong LS
    Bioorg Med Chem; 2009 May; 17(10):3733-8. PubMed ID: 19375920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design of sulfonated A3 adenosine receptor-selective nucleosides as pharmacological tools to study chronic neuropathic pain.
    Paoletta S; Tosh DK; Finley A; Gizewski ET; Moss SM; Gao ZG; Auchampach JA; Salvemini D; Jacobson KA
    J Med Chem; 2013 Jul; 56(14):5949-63. PubMed ID: 23789857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Activity Analysis of Biased Agonism at the Human Adenosine A3 Receptor.
    Baltos JA; Paoletta S; Nguyen AT; Gregory KJ; Tosh DK; Christopoulos A; Jacobson KA; May LT
    Mol Pharmacol; 2016 Jul; 90(1):12-22. PubMed ID: 27136943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.